TickerFactsScreenerDevelopers

BioNexus Gene Lab Corp (BGLC) — Operating Income

Annual figures by fiscal year, from SEC filings.

2018: $59.9K2019: -$275.7K2020: $1.27M2021: $1.06M2022: -$291.2K2023: -$2.59M2024: -$1.57M2025: -$2.97M-$2.97M
2018Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$2.97M-88.4%
2024-$1.57M+39.3%
2023-$2.59M-790.7%
2022-$291.2K-127.6%
2021$1.06M-17.1%
2020$1.27M+562.0%
2019-$275.7K-560.3%
2018$59.9K—